New painkiller could replace opioids after oral surgery
NCT ID NCT07195669
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new non-opioid drug called suzetrigine (Journavx) to the opioid Norco for pain after wisdom tooth removal or jaw surgery. It involves 76 adults aged 18-45. The goal is to see if suzetrigine controls pain just as well without the risk of addiction or breathing problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Suzetrigine (Journavx)
- What this could lead to
- If it works, this could offer a safer, non-addictive painkiller for dental and jaw surgeries, reducing reliance on opioids.
- What could go wrong
- This is a small, early-phase trial with only 76 people, so results may not apply to everyone. The drug may not control pain as well as opioids in some cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN CONTROL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
LSU Dental School
New Orleans, Louisiana, 70214, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.